Emvita 16 (RUBIMED AG)


Welcome to the PulseAid listing for the Emvita 16 drug offered from RUBIMED AG. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: RUBIMED AG
NON-PROPRIETARY NAME: Aconitum napellus, Opium, Ambergris, Claviceps purpurea sclerotium, Zinc, and Sus scrofa thymus
SUBSTANCE NAME: ACONITUM NAPELLUS; OPIUM; AMBERGRIS; CLAVICEPS PURPUREA SCLEROTIUM; ZINC; SUS SCROFA THYMUS
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-05-07
END MARKETING DATE: 0000-00-00


Emvita 16 HUMAN OTC DRUG Details:

Item DescriptionEmvita 16 from RUBIMED AG
LABELER NAME: RUBIMED AG
DEA SCHEDULE:
ACTIVE STRENGTH: 800; 16; 18; 21; 21; 21([hp_C]/mL; [hp_M]/mL; [hp_M]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL)
START MARKETING DATE: 2015-05-07
END MARKETING DATE: 0000-00-00
PRODUCT ID: 66343-028_3adc6f0b-f7cd-4bc2-bab9-0f7e736ecfa1
PRODUCT NDC: 66343-028
APPLICATION NUMBER:

Other ACONITUM NAPELLUS; OPIUM; AMBERGRIS; CLAVICEPS PURPUREA SCLEROTIUM; ZINC; SUS SCROFA THYMUS Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
RUBIMED AGEmvita 16